Dr Jane Harrold Ph.D

Clinical Trial Co-ordinator Women's & Children's Health

+44 (0)151 706 4189 / +44 (0)151 795 9565
Work email J.Harrold@liverpool.ac.uk

Publications

Filter the publication list

Filter list by type

Show all
Journal article
Conference paper
Chapter
Other

2021

Plasma long-chain omega-3 fatty acid status and risk of recurrent early spontaneous preterm birth: a prospective observational study (Journal article)

Goodfellow, L., Care, A., Harrold, J., Sharp, A., Ivandic, J., Poljak, B., . . . Alfirevic, Z. (2021). Plasma long-chain omega-3 fatty acid status and risk of recurrent early spontaneous preterm birth: a prospective observational study. ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, 100(8), 1401-1411. doi:10.1111/aogs.14147

DOI: 10.1111/aogs.14147

2020

The PLANES study: a protocol for a randomised controlled feasibility study of the placental growth factor (PlGF) blood test-informed care versus standard care alone for women with a small for gestational age fetus at or after 32+0weeks' gestation (Journal article)

Gent, J., Bullough, S., Harrold, J., Jackson, R., Woolfall, K., Andronis, L., . . . Sharp, A. (2020). The PLANES study: a protocol for a randomised controlled feasibility study of the placental growth factor (PlGF) blood test-informed care versus standard care alone for women with a small for gestational age fetus at or after 32+0weeks' gestation. PILOT AND FEASIBILITY STUDIES, 6(1). doi:10.1186/s40814-020-00722-x

DOI: 10.1186/s40814-020-00722-x

Effect of sildenafil on maternal hemodynamics in pregnancies complicated by severe early‐onset fetal growth restriction: planned subgroup analysis from a multicenter randomized placebo‐controlled double‐blind trial (Journal article)

Khalil, A., Sharp, A. N., Cornforth, C., Jackson, R., Mousa, H., Stock, S., . . . Alfirevic, Z. (2020). Effect of sildenafil on maternal hemodynamics in pregnancies complicated by severe early‐onset fetal growth restriction: planned subgroup analysis from a multicenter randomized placebo‐controlled double‐blind trial. Ultrasound in Obstetrics and Gynecology, 55(2), 198-209. doi:10.1002/uog.20851

DOI: 10.1002/uog.20851

2019

A Prediction Model for Short-Term Neonatal Outcomes in Severe Early-Onset Fetal Growth Restriction (Journal article)

Sharp, A., Jackson, R., Cornforth, C., Harrold, J., Turner, M. A., Kenny, L., . . . Alfirevic, Z. (2019). A Prediction Model for Short-Term Neonatal Outcomes in Severe Early-Onset Fetal Growth Restriction. European Journal of Obstetrics and Gynecology and Reproductive Biology, 241, 109-118. doi:10.1016/j.ejogrb.2019.08.007

DOI: 10.1016/j.ejogrb.2019.08.007

Mortality in the UK STRIDER trial of sildenafil therapy for the treatment of severe early-onset fetal growth restriction (Journal article)

Sharp, A., Cornforth, C., Jackson, R., Harrold, J., Turner, M. A., Kenny, L., . . . Alfirevic, Z. (2019). Mortality in the UK STRIDER trial of sildenafil therapy for the treatment of severe early-onset fetal growth restriction. LANCET CHILD & ADOLESCENT HEALTH, 3(3), E2-E3. doi:10.1016/S2352-4642(19)30020-3

DOI: 10.1016/S2352-4642(19)30020-3

2018

Maternal sildenafil for severe fetal growth restriction (STRIDER): a multicentre, randomised, placebo-controlled, double-blind trial (Journal article)

Sharp, A., Cornforth, C., Turner, M. A., Harrold, J., Kenny, L. C., Jackson, R., . . . Alfirevic, Z. (2018). Maternal sildenafil for severe fetal growth restriction (STRIDER): a multicentre, randomised, placebo-controlled, double-blind trial. Lancet Child and Adolescent Health, 2(2), 93-102. doi:10.1016/S2352-4642(17)30173-6

DOI: 10.1016/S2352-4642(17)30173-6

Why choose Liverpool?
It’s an important question. And there are thousands of answers.

Study with Liverpool

Find a course

Search courses

Select type

Our courses

Research with real world impact

Our research

Research

Postgraduate Research

Research and business collaboration

Advancing knowledge to transform lives

About us

Our story

Key information

Our locations

Search